Decisio Health Unveils Clinical Intelligence Platform for the Healthcare Market

Healthcare Software Company Secures $4.5 Million in Second Round Funding

News provided by

May 17, 2016, 09:00 ET

HOUSTON, May 17, 2016 /PRNewswire/ -- Decisio Health, a healthcare software company that helps acute-care provider organizations continually improve their clinical processes, announced today that it has launched the Decisio Health Clinical Intelligence Platform. Based on technology developed at the University of Texas Health Center, the Decisio Clinical Intelligence Platform, which is a FDA 501(k) cleared Class II medical device, gathers and interprets data from existing hospital monitoring systems to provide the most current and valuable information in one easy-to-view location at the bedside.

Decisio Health's Clinical Intelligence Platform is a revolutionary product designed for the clinical care team. The Platform provides unprecedented clinical decision support for clinical care teams, right where they need that support: at the bedside. And its Clinical Bundles help reduce variability of care in hospitals. Decisio Health's Clinical Intelligence Platform. The Clinical Intelligence Platform is the first FDA cleared product that provides the flexibility to meet all the needs of clinicians in acute care settings.

Decisio Health's Clinical Intelligence Platform bedside display shows vital trends and lab snapshots giving care teams immediate access to the data they need to treat their patients. In addition, it digitizes and displays a hospital's own protocols for diagnosis and treatment, reducing the variability of care which can lead to better patient outcomes. Decision support visual alerts are designed with human factors in mind and color coded green, yellow and red so care teams can easily act on clinical information and adhere to hospital protocols.

"The Clinical Intelligence Platform was created for clinicians, by clinicians with a focus on providing real-time relevant data at the point of care," said Bryan Haardt, chief executive officer, Decisio Health. "By arming clinicians with this information they are able to be more patient-focused and proactive in their decision making via simple, visual and instantaneous access to the most critical patient data and trends."

Decisio Health recently closed their second round of funding. Decisio's $2.5M Series A raise was very well received by the market and oversubscribed. The company expanded their Series A, raising $4.5M. The financing round was led by DECLATEX, LLC with participation by the University of Texas Horizon Fund. The company also added Larry Lawson, founder of eCardio, as an investor and board member.

"Decisio Health is a perfect example of an ambitious startup that's taking a remarkable technology developed by UT Health Science Center at Houston researchers into a commercially viable enterprise determined to change the health care landscape," said Julie Goonewardene, UT System Associate Vice Chancellor for Innovation and Strategic Investment and Managing Director of the UT Horizon Fund. "The UT Horizon Fund is dedicated to supporting companies like Decisio Health that are accelerating the pace of moving innovations to the marketplace."

Decisio Health is one of 17 startups that have been funded by the UT Horizon Fund, a formative-stage venture fund that provides capital and support to companies with tangible ties to one of UT System's 14 academic and health institutions.

Unlike other resources, Decisio Health arms clinicians with the immediate, high impact information they need to maximize clinical outcomes. This is achieved in three key ways:

1. Enabling better adherence to a hospital's own protocols by codifying compliance directly into the display of health information at the bedside.

2. Identifying areas of clinical deficiencies that hospitals are often unable to previously establish, enabling the setting of new baseline standards that drive measurable, actionable results that can significantly impact hospital financial health.

3. Improving the care experience by using data to transparently build a bridge between clinicians, patients and family.

To receive a demo of the Decisio Health Patient Dashboard, please contact Andrew Swick, VP Business Development, [email protected], 703-216-7815 or visit http://decisiohealth.com/contact-us2

About Decisio Health

Decisio Health is a healthcare software company that helps acute-care provider organizations continually improve their clinical processes. By combining real time and trending data with a hospital's own protocols, healthcare professionals are able to more easily assess the current state of a patient and more easily adhere to the hospital's standard of care. Based on technology developed at the University of Texas Health Center, the FDA cleared Decisio Health Clinical Intelligence Platform gathers data from existing hospital monitoring systems to intelligently display the most current and valuable information in one easy-to-view location. Decisio Health was named as a finalist in the 2015 Fierce Innovation Awards: Healthcare Edition and the 2016 Seton Healthcare: The Future of Care: Healthcare Innovation Awards.

For more information please visit www.decisiohealth.com.

About UT Horizon Fund

The UT Horizon Fund invests across all industry sectors and, with $50 million in committed capital, strives to be a collaborative co-investor and committed long-term partner. For a complete list of the companies being funded, please visit https://www.uts-innovation.com/horizon-fund.

Contact: Tracy Hartman
[email protected]
978-462-0002 x103

Photo - http://photos.prnewswire.com/prnh/20160516/368238

Logo - http://photos.prnewswire.com/prnh/20160516/368239LOGO

SOURCE Decisio Health